Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



FDA Approves 2 St. Jude Heart Devices

The Food and Drug Administration has approved St. Jude Medical's (NYSE: STJ  ) new Ellipse implantable cardioverter defibrillator (ICD) and its Assura cardiac resynchronization therapy defibrillator (CRT-D), high-voltage devices with new safety features.

According to St. Jude's press release yesterday, the products are designed to promote effectiveness in providing electronic shock therapy while reducing safety risks.

The approvals come as St. Jude's cardiovascular rhythm management (CRM) division, which includes these and similar devices, has faced significant sales pressure. St. Jude's CRM revenue fell by around 6% last year.

St. Jude's U.S. approvals come after the company received European CE Mark approval for the Ellipse and Assura last year. The Ellipse and other ICDs are designed to treat abnormal heart rates, while Assura and other CRT-Ds are designed to manage irregularities in the beating of the heart's lower chambers. Both conditions, if untreated, can lead to potentially fatal outcomes such as sudden cardiac death and heart failure.

The company promises increased safety with the new devices. Dr. Eric S. Fain, president of St. Jude's Implantable Electronics Systems Division, was quoted as saying, "St. Jude Medical strives to deliver the highest levels of patient safety. The new Ellipse ICD and SJM Assura family of devices support those efforts by providing added features that ensure effective therapy delivery."


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2485466, ~/Articles/ArticleHandler.aspx, 9/27/2016 10:18:00 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:01 PM
STJ $79.91 Up +0.85 +1.08%
St. Jude Medical CAPS Rating: **